This important role of CD4+ T cells in the control of primary SARS-CoV-2 infection might also continue for the development of long-term immunity, reflected by the here reported trend to increased SARS-CoV-2-specific and cross-reactive HLA-DR-restricted T cell responses at six months post infection. The gene discussed is CD4; the disease is infection.